We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$218B
AUM Growth
+$27.7B
Cap. Flow
+$35.3B
Cap. Flow %
16.16%
Top 10 Hldgs %
11.23%
Holding
3,840
New
278
Increased
2,380
Reduced
985
Closed
101

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.58B
2
NVDA icon
NVIDIA
NVDA
+$1.08B
3
COST icon
Costco
COST
+$680M
4
BKNG icon
Booking.com
BKNG
+$647M
5
AVGO icon
Broadcom
AVGO
+$559M

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$355M
2
WMT icon
Walmart Inc
WMT
+$348M
3
ZM icon
Zoom
ZM
+$321M
4
MRK icon
Merck
MRK
+$303M
5
LYFT icon
Lyft
LYFT
+$250M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Financials 14.55%
3 Industrials 13.75%
4 Consumer Discretionary 11.6%
5 Healthcare 11.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BATRK icon
2726
Atlanta Braves Holdings Series B
BATRK
$3.13B
$1.07M ﹤0.01%
25,139
+167
+0.7% +$6.94K
HIPO icon
2727
Hippo Holdings
HIPO
$864M
$1.07M ﹤0.01%
41,002
+16,985
+71% +$484K
VEL icon
2728
Velocity Financial
VEL
$697M
$1.07M ﹤0.01%
58,906
-16,158
-22% -$305K
CZNC icon
2729
Citizens & Northern Corp
CZNC
$452M
$1.06M ﹤0.01%
47,616
-531
-1% -$11.8K
OMCL icon
2730
Omnicell
OMCL
$1.68B
$1.06M ﹤0.01%
31,853
-11,067
-26% -$463K
CMPX icon
2731
Compass Therapeutics
CMPX
$351M
$1.06M ﹤0.01%
200,428
+45,210
+29% +$261K
CRSP icon
2732
CRISPR Therapeutics
CRSP
$5.2B
$1.06M ﹤0.01%
22,268
+1,522
+7% +$80.3K
BLND icon
2733
Blend Labs
BLND
$484M
$1.06M ﹤0.01%
623,106
+495,225
+387% +$1.06M
KW
2734
DELISTED
Kennedy-Wilson Holdings
KW
$1.06M ﹤0.01%
97,860
+4,458
+5% +$46.2K
IHG icon
2735
InterContinental Hotels
IHG
$23.8B
$1.06M ﹤0.01%
+7,928
New +$1.09M
CBAN icon
2736
Colony Bankcorp
CBAN
$467M
$1.06M ﹤0.01%
52,909
+5,773
+12% +$113K
SYRE icon
2737
Spyre Therapeutics
SYRE
$9.02B
$1.05M ﹤0.01%
20,874
+3,054
+17% +$115K
FORR icon
2738
Forrester Research
FORR
$225M
$1.05M ﹤0.01%
185,922
+87,257
+88% +$596K
ALKT icon
2739
Alkami Technology
ALKT
$2.02B
$1.05M ﹤0.01%
67,149
-8,486
-11% -$156K
JGRO icon
2740
JPMorgan Active Growth ETF
JGRO
$10.1B
$1.05M ﹤0.01%
12,434
-1,515
-11% -$135K
VMD icon
2741
Viemed Healthcare
VMD
$373M
$1.05M ﹤0.01%
113,740
+65,440
+135% +$545K
HBM icon
2742
Hudbay
HBM
$11.6B
$1.05M ﹤0.01%
+52,082
New +$1.22M
ACRE
2743
Ares Commercial Real Estate
ACRE
$251M
$1.04M ﹤0.01%
217,540
+57,572
+36% +$288K
PRKS icon
2744
United Parks & Resorts
PRKS
$2.16B
$1.04M ﹤0.01%
31,959
+14,835
+87% +$519K
SDVY icon
2745
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.9B
$1.04M ﹤0.01%
26,462
-2,517
-9% -$102K
OUNZ icon
2746
VanEck Merk Gold Trust
OUNZ
$2.62B
$1.04M ﹤0.01%
23,137
+7,242
+46% +$340K
IXN icon
2747
iShares Global Tech ETF
IXN
$8.86B
$1.04M ﹤0.01%
10,413
+5,729
+122% +$605K
PNTG icon
2748
Pennant Group
PNTG
$1.35B
$1.04M ﹤0.01%
34,106
+13,511
+66% +$418K
ESRT icon
2749
Empire State Realty Trust
ESRT
$833M
$1.04M ﹤0.01%
199,286
+111,562
+127% +$670K
GLXY
2750
Galaxy Digital Inc
GLXY
$3.81B
$1.04M ﹤0.01%
56,125
+32,772
+140% +$779K

Similar funds

AQR Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, AQR Capital Management held 3,840 positions worth $218B, up 15% from $191B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

AQR Capital Management deployed $35.3B of net new capital in Q1 2026, opening 278 new positions and adding to 2,380 existing holdings. Its largest new stake was Versant Media Group: 5,801,568 shares worth $211M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Atlassian, an estimated $355M trimmed.

  • AQR Capital Management's largest Q1 2026 buy was Versant Media Group: 5,801,568 shares worth $211M.
  • AQR Capital Management added most to Microsoft in Q1 2026, an estimated $1.58B increase.
  • AQR Capital Management's biggest Q1 2026 reduction was Atlassian, cutting an estimated $355M.
  • AQR Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $226M.
  • AQR Capital Management's ten largest holdings make up 11% of its $218B portfolio in Q1 2026.
  • AQR Capital Management opened 278 new positions and closed 101 in Q1 2026.
  • AQR Capital Management's portfolio value rose 15% quarter-over-quarter to $218B.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.